| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |